Infections caused by Streptococcus pneumoniae bacteria, including pneumonia, meningitis, and bloodstream infections. Multiple vaccines available for different age groups.
Pneumococcal disease is caused by Streptococcus pneumoniae bacteria (pneumococcus). It can cause pneumonia, otitis media (ear infections), sinusitis, meningitis, and bacteremia. Pneumococcus is a leading cause of bacterial pneumonia deaths worldwide (CDC, 2024).
In the U.S., pneumococcal pneumonia causes approximately 150,000 hospitalizations annually. Meningitis and bloodstream infections are less common but more severe, with fatality rates of 10-20% for meningitis.
Latest conjugate vaccine. Covers 20 serotypes. Single dose for adults 65+ or high-risk.
Covers 15 serotypes. When followed by PPSV23, provides broad protection.
Covers 13 serotypes. Standard childhood series. Adults 65+ may discuss with doctor.
Covers 23 serotypes. Used in sequence with PCV for high-risk groups and adults 65+.
Vaccination remains the most effective strategy for preventing pneumococcal disease. The following describes established medical consensus for clinical management.
Treatment depends on the clinical syndrome. Pneumococcal pneumonia is treated with targeted antibiotics — Penicillin or Amoxicillin for susceptible strains, Cephalosporins or Fluoroquinolones for resistant strains. Antibiotic susceptibility testing guides therapy as resistance patterns vary by region. Supportive respiratory care including supplemental oxygen is important for pneumonia. Pneumococcal meningitis follows the same emergency protocol as bacterial meningitis (Vancomycin plus Ceftriaxone plus Dexamethasone).
Disclaimer: This information is for educational purposes only. Treatment decisions must be made by a qualified healthcare provider.